179 related articles for article (PubMed ID: 12941063)
1. Insomnia related to postmenopausal syndrome and hormone replacement therapy: sleep laboratory studies on baseline differences between patients and controls and double-blind, placebo-controlled investigations on the effects of a novel estrogen-progestogen combination (Climodien, Lafamme) versus estrogen alone.
Saletu-Zyhlarz G; Anderer P; Gruber G; Mandl M; Gruber D; Metka M; Huber J; Oettel M; Gräser T; Abu-Bakr MH; Grätzhofer E; Saletu B
J Sleep Res; 2003 Sep; 12(3):239-54. PubMed ID: 12941063
[TBL] [Abstract][Full Text] [Related]
2. Hormone replacement therapy and vigilance: double-blind, placebo-controlled EEG-mapping studies with an estrogen-progestogen combination (Climodien, Lafamme) versus estrogen alone in menopausal syndrome patients.
Saletu B; Anderer P; Gruber D; Metka M; Huber J; Saletu-Zyhlarz GM
Maturitas; 2002 Nov; 43(3):165-81. PubMed ID: 12443834
[TBL] [Abstract][Full Text] [Related]
3. Effects of hormone replacement therapy on perceptual and cognitive event-related potentials in menopausal insomnia.
Anderer P; Semlitsch HV; Saletu B; Saletu-Zyhlarz G; Gruber D; Metka M; Huber J; Gräser T; Oettel M
Psychoneuroendocrinology; 2003 Apr; 28(3):419-45. PubMed ID: 12573306
[TBL] [Abstract][Full Text] [Related]
4. Double-blind, placebo-controlled psychometric studies on the effects of a combined estrogen-progestin regimen versus estrogen alone on performance, mood and personality of menopausal syndrome patients.
Linzmayer L; Semlitsch HV; Saletu B; Böck G; Saletu-Zyhlarz G; Zoghlami A; Gruber D; Metka M; Huber J; Oettel M; Gräser T; Grünberger J
Arzneimittelforschung; 2001; 51(3):238-45. PubMed ID: 11304940
[TBL] [Abstract][Full Text] [Related]
5. Brain regions activated during an auditory discrimination task in insomniac postmenopausal patients before and after hormone replacement therapy: low-resolution brain electromagnetic tomography applied to event-related potentials.
Anderer P; Saletu B; Saletu-Zyhlarz G; Gruber D; Metka M; Huber J; Pascual-Marqui RD
Neuropsychobiology; 2004; 49(3):134-53. PubMed ID: 15034229
[TBL] [Abstract][Full Text] [Related]
6. Sleep, vigilance and cognition in postmenopausal women: placebo-controlled studies with 2 mg estradiol valerate, with and without 3 mg dienogest.
Saletu B
Climacteric; 2003 Aug; 6 Suppl 2():37-45. PubMed ID: 14669843
[TBL] [Abstract][Full Text] [Related]
7. Placebo-controlled sleep laboratory studies on the acute effects of zolpidem on objective and subjective sleep and awakening quality in nonorganic insomnia related to neurotic and stress-related disorder.
Saletu-Zyhlarz G; Anderer P; Brandstätter N; Dantendorfer K; Gruber G; Mandl M; Ritter K; Zoghlami A; Saletu B
Neuropsychobiology; 2000; 41(3):139-48. PubMed ID: 10754428
[TBL] [Abstract][Full Text] [Related]
8. Nonorganic insomnia in generalized anxiety disorder. 2. Comparative studies on sleep, awakening, daytime vigilance and anxiety under lorazepam plus diphenhydramine (Somnium) versus lorazepam alone, utilizing clinical, polysomnographic and EEG mapping methods.
Saletu B; Saletu-Zyhlarz G; Anderer P; Brandstätter N; Frey R; Gruber G; Klösch G; Mandl M; Grünberger J; Linzmayer L
Neuropsychobiology; 1997; 36(3):130-52. PubMed ID: 9313245
[TBL] [Abstract][Full Text] [Related]
9. Identifying target regions for vigilance improvement under hormone replacement therapy in postmenopausal syndrome patients by means of electroencephalographic tomography (LORETA).
Saletu B; Anderer P; Saletu-Zyhlarz GM; Gruber D; Metka M; Huber J
Psychopharmacology (Berl); 2005 Apr; 178(4):389-99. PubMed ID: 15765254
[TBL] [Abstract][Full Text] [Related]
10. Influence of a continuous combined HRT (2 mg estradiol valerate and 2 mg dienogest) on postmenopausal depression.
Rudolph I; Palombo-Kinne E; Kirsch B; Mellinger U; Breitbarth H; Gräser T
Climacteric; 2004 Sep; 7(3):301-11. PubMed ID: 15669555
[TBL] [Abstract][Full Text] [Related]
11. Comparison of the efficacy and endometrial safety of two estradiol valerate/dienogest combinations and Kliogest for continuous combined hormone replacement therapy in postmenopausal women.
Gräser T; Koytchev R; Müller A; Oettel M
Climacteric; 2000 Jun; 3(2):109-18. PubMed ID: 11910651
[TBL] [Abstract][Full Text] [Related]
12. Climodien (estradiol valerate 2 mg plus dienogest 2 mg) is safe and effective in the treatment of postmenopausal complaints.
Gräser T; Römer T; Wiedey KD; Janaud A
Climacteric; 2001 Dec; 4(4):332-42. PubMed ID: 11770190
[TBL] [Abstract][Full Text] [Related]
13. Insomnia in somatoform pain disorder: sleep laboratory studies on differences to controls and acute effects of trazodone, evaluated by the Somnolyzer 24 x 7 and the Siesta database.
Saletu B; Prause W; Anderer P; Mandl M; Aigner M; Mikova O; Saletu-Zyhlarz GM
Neuropsychobiology; 2005; 51(3):148-63. PubMed ID: 15838186
[TBL] [Abstract][Full Text] [Related]
14. Insomnia in depression: differences in objective and subjective sleep and awakening quality to normal controls and acute effects of trazodone.
Saletu-Zyhlarz GM; Abu-Bakr MH; Anderer P; Gruber G; Mandl M; Strobl R; Gollner D; Prause W; Saletu B
Prog Neuropsychopharmacol Biol Psychiatry; 2002 Feb; 26(2):249-60. PubMed ID: 11817501
[TBL] [Abstract][Full Text] [Related]
15. The role of antiandrogens in hormone replacement therapy.
Schneider HP
Climacteric; 2000 Dec; 3 Suppl 2():21-7. PubMed ID: 11379383
[TBL] [Abstract][Full Text] [Related]
16. Sleep laboratory studies in restless legs syndrome patients as compared with normals and acute effects of ropinirole. 1. Findings on objective and subjective sleep and awakening quality.
Saletu B; Gruber G; Saletu M; Brandstätter N; Hauer C; Prause W; Ritter K; Saletu-Zyhlarz G
Neuropsychobiology; 2000; 41(4):181-9. PubMed ID: 10828727
[TBL] [Abstract][Full Text] [Related]
17. A multicenter, prospective, randomized, double-blind, placebo-controlled study to investigate the efficacy of a continuous-combined hormone therapy preparation containing 1mg estradiol valerate/2mg dienogest on hot flushes in postmenopausal women.
Endrikat J; Graeser T; Mellinger U; Ertan K; Holz C
Maturitas; 2007 Oct; 58(2):201-7. PubMed ID: 17889463
[TBL] [Abstract][Full Text] [Related]
18. Insomnia in generalized anxiety disorder: polysomnographic, psychometric and clinical investigations before, during and after therapy with a long- versus a short-half-life benzodiazepine (quazepam versus triazolam).
Saletu B; Anderer P; Brandstätter N; Frey R; Grünberger J; Klösch G; Mandl M; Wetter T; Zeitlhofer J
Neuropsychobiology; 1994; 29(2):69-90. PubMed ID: 8170529
[TBL] [Abstract][Full Text] [Related]
19. Theophylline in snoring and sleep-related breathing disorders: sleep laboratory investigations on subjective and objective sleep and awakening quality.
Oberndorfer S; Saletu B; Gruber G; Anderer P; Saletu M; Mandl M; Saletu-Zyhlarz G
Methods Find Exp Clin Pharmacol; 2000 May; 22(4):237-45. PubMed ID: 10939035
[TBL] [Abstract][Full Text] [Related]
20. A one-year randomized double-blind, multicentre study to evaluate the effects of an oestrogen-reduced, continuous combined hormone replacement therapy preparation containing 1 mg oestradiol valerate and 2 mg dienogest on metabolism in postmenopausal women.
Endrikat J; Lange E; Kunz M; Schmidt W; Graeser T
Eur J Contracept Reprod Health Care; 2007 Sep; 12(3):229-39. PubMed ID: 17763261
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
